CompletedPhase 4

Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

Belgium120 participantsStarted 2011-11

Plain-language summary

The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.

Who can participate

Age range38 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Intra-cytoplasmic sperm injection (ICSI) patients below 38 years * 1,2 or 3 rd IVF-cycle Exclusion Criteria: * polycystic ovary syndrome (PCOS) patients * patients with endocrinological diseases or problems

What they're measuring

MII Oocytes

Timeframe: 3 weeks

Trial details

NCT IDNCT01607203

SponsorAZ Jan Palfijn Gent

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12

Results submitted2013-12-30

View on ClinicalTrials.gov More Infertility trials